NAGE SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 6, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Niagen Bioscience Reports Third Quarter 2026 Financial Results and Operational Updates

Nov 4, 2026

8-K

Niagen Bioscience Reports Q2 2026 Financial Results and Strategic Expansion into Pharmaceuticals and Telehealth

Aug 4, 2026

8-K

Niagen Bioscience, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 29, 2026

8-K

Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results

May 6, 2026

8-K

Niagen Bioscience Increases Share Repurchase Program to $20 Million

Mar 19, 2026

8-K

Niagen Bioscience Reports 30% YoY Net Sales Growth to $129.4M and 103% Net Income Increase to $17.4M for Fiscal Year 2025

Mar 4, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

July 2026 ATM | Offering amount: $50,000,000 | Bank: Canaccord Genuity LLC; Roth Capital Partners, LLC

Jul 10, 2026

424B3

UPDATED | ATM | Offering amount: $47,800,000.00

Nov 21, 2024

424B5

ATM | Offering amount: $47,800,000

Jul 6, 2023

424B3

UPDATED

Nov 17, 2022

424B5

SHELF OFFERING | Shares amount: 3,816,794 | Share price: $1.31

Oct 11, 2022

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 3,846,153 | Share price: $6.50

Apr 22, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-3

June 2026 SHELF + ATM

Jun 26, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 8, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 8, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 22, 2023

S-3

SHELF | ATM | Offering amount: $125,000,000.00 EFFECTIVE

Jun 22, 2023

S-3

SHELF EFFECTIVE

Nov 3, 2022

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

BlackRock, Inc. (Filed by)

Jul 29, 2026

Lopez Carlos Luis (Reporting)

Jul 8, 2026

Pamir Ozan (Reporting)

Jul 8, 2026

Fried Robert N (Reporting)

Jul 8, 2026

S-3

Form S-3 - Registration statement under Securities Act of 1933

Jun 26, 2026

YU Wing Tak Wendy (Reporting)

Jun 26, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 10, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 6, 2023

CORRESP

Form CORRESP - Correspondence

Jun 30, 2023

LETTER

Form UPLOAD - SEC-generated letter

Jun 27, 2023

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 17, 2022

CORRESP

Form CORRESP - Correspondence

Nov 14, 2022

Niagen Bioscience Inc NAGE · SEC Filings